Safety of transglutaminase-induced corneal collagen cross-linking on the central cornea thickness and intraocular pressure in vivo
F1000Research · 25.06.2026 · 12 · 48
DOI: 10.12688/f1000research.129694.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift F1000Research, online erschienen am 25.06.2026. Verfasst von Puspita Hapsari Sitorasmi und 3 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitas Airlangga.
Abstract (Originalsprache)
Background
Corneal collagen cross-linking (CXL) is a procedure for making bonds that connect polymer chains to one another. Corneal CXL aims to slow or stop the progression of keratoconus by using photooxidative therapy so as to increase stromal rigidity. Transglutaminase enzymes are currently widely used in the food industry. Recent studies have shown that mRNA, fibronectin, and transglutaminase were found to be more abundant in human corneal keratocytes treated with UVA and riboflavin. Transglutaminase is considered to reduce discomfort caused by UVA irradiation.
Methods
A total of 21 white New Zealand rabbits were divided into three groups, namely, transglutaminase-induced CXL group, epithelial-off CXL group, and transepithelial CXL group. The ocular surface was treated with a 1 U/mL microbial transglutaminase solution, and both the epithelial-off and transepithelial groups were exposed to clinical ultraviolet A-riboflavin (UVA/RF). The efficacy of each group was evaluated on the 14 th day after the procedures. The central corneal thickness (CCT) and intraocular pressure (IOP) were evaluated using Corneal Visualization Scheimpflug Technology (Corvis ST).
Results
The transglutaminase-induced CXL group exhibited the mean CCT of 355.14 ± 33.58 μm in comparison with the UVA/RF epithelial-off group (370.14 ± 43.04 μm) and the UVA/RF transepithelial group (369.86 ± 23.43 μm). The transglutaminase-induced CXL group had the highest IOP median 8.50 (5.50) mmHg compared with the UVA/RF epithelial-off 6.50 (6.00) mmHg and UVA/RF transepithelial groups 7.00 (3.50) mmHg. There were no significant differences in CCT ( p = 0.65) or IOP ( p = 0.26) between the groups.
Conclusions
The findings of this study suggest that there are no significant differences between the transglutaminase-induced CXL group and the UVA/RF CXL group. The safety of transglutaminase-induced CXL could be comparable to that of UVA/RF CXL in terms of altering CCT and IOP, which are two factors contributing to corneal rigidity.
Förderung
- Universitas Airlangga
Zitieren
APA
Sitorasmi, P. H., Ningtiyas, Y. S., Wahyuni, I., & Primitasari, Y. (2026). Safety of transglutaminase-induced corneal collagen cross-linking on the central cornea thickness and intraocular pressure in vivo. F1000Research, 12, 48. https://doi.org/10.12688/f1000research.129694.2
Vancouver
Sitorasmi PH, Ningtiyas YS, Wahyuni I, Primitasari Y. Safety of transglutaminase-induced corneal collagen cross-linking on the central cornea thickness and intraocular pressure in vivo. F1000Research. 2026;12:48. doi:10.12688/f1000research.129694.2
BibTeX
@article{Sitorasmi2026,
author = {Sitorasmi, Puspita Hapsari and Ningtiyas, Yuniar Sarah and Wahyuni, Indri and Primitasari, Yulia},
title = {Safety of transglutaminase-induced corneal collagen cross-linking on the central cornea thickness and intraocular pressure in vivo},
journal = {F1000Research},
year = {2026},
volume = {12},
pages = {48},
doi = {10.12688/f1000research.129694.2}
}
EUVIMED